| # | Drug | Count |
|---|---|---|
| 0 | SERTRALINE | 23 |
| 1 | LAMOTRIGINE | 18 |
| 2 | IBUPFROFEN | 17 |
| 3 | IBUPROFEN | 17 |
| 4 | IBUPROFEN 200 MG | 17 |
| 5 | IBUPROFEN 200MG | 17 |
| 6 | IBUPROFEN CAPSULE | 17 |
| 7 | IBUPROFEN CAPSULES 200 MG | 17 |
| 8 | IBUPROFEN ORAL | 17 |
| 9 | IBUPROFEN TABLET, FILM COATED | 17 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | EFAVIRENZ, LAMIVUDINE AND TENOFOVIR DISOPROXIL FUMARATE | 1 | 0.0333 |
| 1 | .BETA.-CAROTENE, ASCORBIC ACID, CHOLECALCIFEROL, .ALPHA.-TOCOPHEROL ACETATE, DL-, THIAMINE MONONITRATE, RIBOFLAVIN, NIACINAMIDE, PYRIDOXINE HYDROCHLORIDE, FOLIC ACID, LEVOMEFOLATE CALCIUM, CALCIUM FORMATE, FERROUS ASPARTO GLYCINATE, CYANOCOBALAMIN, BIOTIN, POTASSIUM IODIDE, MAGNESIUM OXIDE, ZINC OXIDE AND CUPRIC OXIDE | 1 | 0.0278 |
| 2 | RALTEGRAVIR | 14 | 0.0027 |
| 3 | DORAVIRINE | 2 | 0.0025 |
| 4 | DOLUTEGRAVIR SODIUM AND LAMIVUDINE | 6 | 0.0017 |
| 5 | DOLUTEGRAVIR SODIUM | 13 | 0.0014 |
| 6 | LAMIVUDINE AND ZIDOVUDINE | 11 | 0.0014 |
| 7 | ALBENDAZOLE | 2 | 0.0011 |
| 8 | NELFINAVIR MESYLATE | 2 | 0.0010 |
| 9 | AMPICILLIN INJECTION | 7 | 0.0009 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Anthelmintic [EPC] | 2 | 0.0007 |
| 1 | Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] | 22 | 0.0004 |
| 2 | CCR5 Co-receptor Antagonist [EPC] | 1 | 0.0004 |
| 3 | Protease Inhibitor [EPC] | 17 | 0.0004 |
| 4 | Progesterone [EPC] | 8 | 0.0003 |
| 5 | Human Immunodeficiency Virus 1 Non-Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] | 7 | 0.0003 |
| 6 | Antimycobacterial [EPC] | 7 | 0.0003 |
| 7 | Cytochrome P450 3A Inhibitor [EPC] | 17 | 0.0003 |
| 8 | Serotonin-1b and Serotonin-1d Receptor Agonist [EPC] | 7 | 0.0003 |
| 9 | Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] | 29 | 0.0003 |